Kymera Therapeutics, Inc. (KYMR) Balance Sheet Quarterly

Kymera Therapeutics, Inc.

KYMR (NASDAQ)

(%)

Financials
Kymera Therapeutics, Inc. Balance Sheet Statement Quarterly

Annual Quarterly

* (except for per share items) of USD

Period Ending:	2025 (Q3) 09-30	2025 (Q2) 06-30	2025 (Q1) 03-31	2024 (Q4) 12-31	2024 (Q3) 09-30	2024 (Q2) 06-30	2024 (Q1) 03-31
Report Filing:	2025-11-04	2025-08-11	2025-05-09	2025-02-27	2024-10-31	2024-08-07	1234
Total Current Assets	528.3	728.3	501	510.3	568.7	525.4	1234
Cash and Short Term Investments	505.7	665.4	463.1	488.7	550	510	1234
Cash & Equivalents	112.9	335.8	89.97	120.3	110.7	67.61	1234
Short Term Investments	392.7	329.6	373.2	368.5	439.3	442.3	1234
Receivables	0	40	20	0.947	1.32	1.7	1234
Inventory	0	0	0	0	0	0	1234
Other Current Assets	22.62	22.88	17.8	20.58	17.43	13.75	1234
Total Assets	1,102	1,131	918.3	978	1,035	826	1234
Total Non-Current Assets	573.7	402.7	417.4	467.8	466.1	300.6	1234
Property, Plant and Equipment	88.08	94.62	95.91	97.86	99.31	100.4	1234
Goodwill and Intangible Assets	0	0	0	0	0	0	1234
Goodwill	0	0	0	0	0	0	1234
Intangible Assets	0	0	0	0	0	0	1234
Long Term Investments	478.8	303.4	312.3	362.2	361	192.4	1234
Deferred Tax Assets	0	0	0	0	0	0	1234
Other Long Term Assets	6.83	4.67	9.12	7.74	5.78	7.73	1234
Total Current Liabilities	71.58	87.54	58.99	67.77	66.53	62.14	1234
Accounts Payable	5.51	5.78	10.26	5.99	6.49	6.51	1234
Notes Payable/Short Term Debt	13.74	13.67	13.24	13.11	12.85	12.42	1234
Tax Payables	0	0	0	0	0	0	1234
Deferred Revenue	23.28	40	11.48	13.58	20.02	19.26	1234
Other Current Liabilities	29.05	28.09	24.01	35.09	27.16	23.96	1234
Total Liabilities	155.8	159.6	132.1	142.4	141.9	141.1	1234
Total Non-Current Liabilities	84.21	72.05	73.09	74.65	75.38	78.95	1234
Total Long Term Debt	70.25	72.05	73.09	74.65	75.38	75.77	1234
Deferred Tax Liabilities Non-Current	0	0	0	0	0	0	1234
Deferred Revenue Non-Current	13.96	0	0	0	0	3.19	1234
Capital Lease Obligations	70.25	85.71	86.33	87.76	88.23	88.18	1234
Other Long Term Liabilities	-70.25	-85.71	-86.33	-87.76	-88.23	-88.18	1234
Total Equity	946.3	971.5	786.2	835.6	892.9	684.9	1234
Non-Controlling Interest	0	0	0	0	0	0	1234
Total Stockholders' Equity	946.3	971.5	786.2	835.6	892.9	684.9	1234
Retained Earnings	-979	-896.8	-820.2	-754.6	-683.9	-621.4	1234
Accumulated Other Earnings	1.5	0.279	-0.058	-1.49	1.93	-2.1	1234
Common Stock	0.007	0.007	0.007	0.007	0.007	0.006	1234
Preferred Stock	0	0	0	0	0	0	1234
Additional Paid in Capital	1,924	1,868	1,606	1,592	1,575	1,308	1234
Total Liabilities & Total Equity	1,102	1,131	918.3	978	1,035	826	1234
Total Liabilities & Shareholders' Equity	1,102	1,131	918.3	978	1,035	826	1234
Total Investments	871.6	633.1	685.5	730.6	800.3	634.8	1234
Total Debt	84	85.71	86.33	87.76	88.23	88.18	1234
Net Debt	-28.95	-250.1	-3.64	-32.49	-22.49	20.57	1234

Market is Open

After-Hours Quote

Market is Open

After-Hours Quote

Kymera Therapeutics, Inc. Balance Sheet Statement Quarterly